Abemaciclib metabolite M2 (LSN2839567) is a metabolite of Abemaciclib, acts as a potent CDK4 and CDK6 inhibitor, with IC50s of 1.2 and 1.3 nM, respectively. Anti-cancer activity.
性状
Solid
IC50 & Target[1][2]
CDK4
1.2 nM (IC50)
CDK6
1.3 nM (IC50)
体内研究(In Vivo)
Abemaciclib metabolite M2 (LSN2839567) is bound to plasma proteins in rat, dog and human (83-92%), lower than Abemaciclib (95-99%).
Abemaciclib metabolite M2 is the most prominent (active and major) plasma metabolites in human.
Medlife has not independently confirmed the accuracy of these methods. They are for reference only.